Author

Aya Gouma

Zagazig University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Assay:scRNA-seq· 1 Approach:statistical model· 1

Frequent Co-Authors

Alastair SmithiD· 1 shared Alexander Winton· 1 shared Alexandra Curran· 1 shared Anindita RoyiD· 1 shared Brenda E. S. Gibson· 1 shared Christine J. HarrisoniD· 1 shared David L.P. VetrieiD· 1 shared Elżbieta KaniaiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alastair SmithORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

CD180 identifies chemoresistant stem-like blasts and reveals a KMT2A-driven vulnerability in acute myeloid leukaemia

Madonna M. Eltoukhy, Alexander Winton, Francesca Fasanella Masci, Elżbieta Kania, Mary T. Scott, Alastair Smith, Evie Rigby, Alexandra Curran, Aya Gouma, Jennifer E. Cassels, Lijun Liu, Thomas Stevens, Karen M. Dunn, Kevin M. Rattigan, Meaad almowaled, , Karen Keeshan

This paper identifies CD180 as a marker for chemoresistant stem-like blasts in KMT2A-rearranged paediatric AML, showing its absence on normal HSCs and its role as a therapeutic target.

bioRxiv · Apr 27, 2026 · PreprintCancer Biology